| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | This Is What Whales Are Betting On Sarepta Therapeutics | 7 | Benzinga.com | ||
| 08.04. | Why Sarepta's First-Quarter Report Is Already Dead In The Water: Analyst | 8 | Investor's Business Daily | ||
| 22.03. | Italfarmaco nabs FDA approval for new nonsteroidal Duchenne muscular dystrophy med, teeing up sparring match with Sarepta | 12 | FiercePharma | ||
| 13.03. | Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling? | 8 | The Motley Fool | ||
| 04.03. | Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst | 13 | The Motley Fool | ||
| 01.03. | UBS raises Sarepta Therapeutics shares target on label outlook | 12 | Investing.com | ||
| 01.03. | Earnings call: Sarepta reports robust Q4 growth, fueled by ELEVIDYS launch | 4 | Investing.com | ||
| 29.02. | Sarepta details Elevidys launch progress while awaiting key FDA decision on label expansion | 7 | FiercePharma | ||
| 29.02. | Sarepta (SRPT) Q4 Earnings Beat Estimates, Revenues Up Y/Y | 9 | Zacks | ||
| 29.02. | US Okta, Salesforce, Sarepta Therapeutics | 23 | Reuters | ||
| 29.02. | Sarepta Therapeutics Inc reports results for the quarter ended in December - Earnings Summary | 8 | Reuters | ||
| 28.02. | Sarepta Therapeutics Q4 Earnings Summary | 422 | AFX News | WASHINGTON (dpa-AFX) - Below are the earnings highlights for Sarepta Therapeutics (SRPT):Earnings: $45.66 million in Q4 vs. -$109.24 million in the same period last year.
EPS: $0.47 in Q4... ► Artikel lesen | |
| 28.02. | Sarepta Therapeutics: Q4 Earnings Insights | 4 | Benzinga.com | ||
| 28.02. | Sarepta Therapeutics Non-GAAP EPS of $0.82 beats by $0.45, revenue of $396.78M beats by $10.62M | 9 | Seeking Alpha | ||
| 28.02. | Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments | 96 | Business Wire | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the fourth quarter... ► Artikel lesen | |
| 28.02. | Sarepta Therapeutics, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 28.02. | Is It Too Late to Buy Sarepta Therapeutics Stock? | 7 | The Motley Fool | ||
| 27.02. | A Preview Of Sarepta Therapeutics' Earnings | 5 | Benzinga.com | ||
| 21.02. | Sarepta (SRPT) to Report Q4 Earnings: Will It Beat Estimates? | 11 | Zacks | ||
| 19.02. | Sarepta's (SRPT) DMD Drug sBLA Gets FDA's Priority Tag, Stock Up | 3 | Zacks |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 457 |
| NVIDIA | 296 |
| DEUTSCHE BANK | 292 |
| BAYER | 231 |
| NEL | 208 |
| TESLA | 199 |
| RHEINMETALL | 156 |
| SUPER MICRO COMPUTER | 154 |
| TUI | 154 |
| BYD | 150 |
| THYSSENKRUPP | 133 |
| BASF | 123 |
| COMMERZBANK | 120 |
| PLUG POWER | 113 |
| GALERIA KARSTADT KAUFHOF GMBH | 111 |
| AIXTRON SE | 110 |
| MICROSOFT | 110 |
| AMAZON | 109 |
| INTEL | 102 |
| META PLATFORMS | 100 |
| RWE | 98 |
| ALPHABET | 95 |
| DELIVERY HERO | 94 |
| PAYPAL | 90 |
| VOLKSWAGEN | 82 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
